Effects of SGLT2 inhibitors on anemia in patients with diabetes and chronic kidney disease: A population-based cohort study using target trial emulation framework

被引：0
|
作者：
Hu, Jia-Chian [1 ]
Shao, Shih-Chieh [2 ]
Tsai, Daniel Hsiang-Te [1 ]
Chuang, Albert Tzu-Ming [1 ]
Liu, Kuan-Hung [3 ]
Lai, Edward Chia-Cheng [1 ]
机构：
[1] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[2] Keelung Chang Gung Mem Hosp, Keelung, Taiwan
[3] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
160
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [41] Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
    Kovesdy, Csaba
    Schmedt, Niklas
    Folkerts, Kerstin
    Bowrin, Kevin
    Raad, Hanaya
    Batech, Michael
    Fried, Linda
    BMC MEDICINE, 2022, 20 (01)
  • [42] SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease Jigsaw Falling Into Place
    Kristensen, Soren L.
    Jensen, Jesper
    Schou, Morten
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (19) : 1915 - 1917
  • [43] Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
    Csaba Kovesdy
    Niklas Schmedt
    Kerstin Folkerts
    Kevin Bowrin
    Hanaya Raad
    Michael Batech
    Linda Fried
    BMC Medicine, 20
  • [44] Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
    Chun-Yu Chen
    Sheng-Wei Pan
    Chia-Chen Hsu
    Jason J. Liu
    Hiraku Kumamaru
    Yaa-Hui Dong
    Respiratory Research, 24
  • [45] Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
    Chen, Chun-Yu
    Pan, Sheng-Wei
    Hsu, Chia-Chen
    Liu, Jason J.
    Kumamaru, Hiraku
    Dong, Yaa-Hui
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [46] Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation framework
    Chen, Anthony
    Ju, Chengsheng
    Mackenzie, Isla S.
    MacDonald, Thomas M.
    Struthers, Allan D.
    Wei, Li
    Man, Kenneth K. C.
    LANCET REGIONAL HEALTH-EUROPE, 2023, 33
  • [47] Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
    Zhao, Li-Min
    Zhan, Ze-Lin
    Ning, Jie
    Qiu, Mei
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [48] The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study
    Agur, Timna
    Steinmetz, Tali
    Goldman, Shira
    Zingerman, Boris
    Bielopolski, Dana
    Nesher, Eviatar
    Fattal, Ittai
    Meisel, Eshcar
    Rozen-Zvi, Benaya
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [49] The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study
    Siao, W. Z.
    Jong, G. P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3064 - 3064
  • [50] The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study
    Hung-Yi Chen
    Jing-Yang Huang
    Wun-Zhih Siao
    Gwo-Ping Jong
    Cardiovascular Diabetology, 19
12345